Photograph by Ali Lapetina Letter | 14 April 2021 Letter from civil society organisations to US President Biden on TRIPS Waiver for COVID-19 medical tools COVID-19 Download COVID19_Letter_TRIPSWaiverSignOnLetter_ENG_022621 Photograph by Ali Lapetina Read, watch, share Filter by - Any -BlogEventsExplainerFeature storyInterviewIssue briefLetterNewsletterOpinion articlePress releaseSpeechSpotlightStatementTechnical briefVideo Photograph by Mariana Abdalla Explainer Explainer | 08 March 2022 COVID-19 Latin America: How patents and licensing hinder access to COVID-19 treatments 3 min Photograph by Pierre Fromentin Press release Press release | 22 February 2022 COVID-19 Landmark ‘TRIPS Waiver’ must be agreed now: no time to lose 5 min Photograph by MSF Press release Press release | 18 February 2022 COVID-19 Africa MSF responds to WHO announcement that 6 countries will receive tech from mRNA COVID-19 hub 4 min Letter | 16 February 2022 COVID-19 Civil society open letter to the WTO Director General Blog Blog | 12 February 2022 COVID-19 COVAX — A broken promise for vaccine equity Technical brief | 28 January 2022 COVID-19 South Africa Removing intellectual-property barriers from COVID-19 vaccines and treatments for people in South Africa Photograph by Nikhil Roshan Press release Press release | 14 January 2022 COVID-19 MSF responds to latest WHO recommendation for a COVID-19 therapeutic, baricitinib 3 min Photograph by Pierre Fromentin Press release Press release | 23 December 2021 COVID-19 MSF responds to FDA approval of COVID-19 drug molnupiravir 3 min Load More
Photograph by Mariana Abdalla Explainer Explainer | 08 March 2022 COVID-19 Latin America: How patents and licensing hinder access to COVID-19 treatments 3 min
Photograph by Pierre Fromentin Press release Press release | 22 February 2022 COVID-19 Landmark ‘TRIPS Waiver’ must be agreed now: no time to lose 5 min
Photograph by MSF Press release Press release | 18 February 2022 COVID-19 Africa MSF responds to WHO announcement that 6 countries will receive tech from mRNA COVID-19 hub 4 min
Technical brief | 28 January 2022 COVID-19 South Africa Removing intellectual-property barriers from COVID-19 vaccines and treatments for people in South Africa
Photograph by Nikhil Roshan Press release Press release | 14 January 2022 COVID-19 MSF responds to latest WHO recommendation for a COVID-19 therapeutic, baricitinib 3 min
Photograph by Pierre Fromentin Press release Press release | 23 December 2021 COVID-19 MSF responds to FDA approval of COVID-19 drug molnupiravir 3 min
